Renovacor (Series A)
Funding Details
- Awarder
- Inbox
- Date Award
- August 14, 2019
- Vertical
- Biotechnology
- Funding URL
- View Funding Page
- Funding Amount:
- $11,000,000
Company Info
- Company Description
- Renovacor is a preclinical stage biotechnology company whose mission is to develop improved therapies for genetically derived cardiovascular diseases. The company is currently developing a gene therapy for a rare, familial form of dilated cardiomyopathy.
- Market
- Cardiovascular diseases
- Location
- Philadelphia, PA, USA
- Coinvestors
- BioAdvance, Broadview Ventures, Innogest Capital, New Leaf Venture Partners, Novartis Venture Fund